Clinical trial
Psychosocial and Medication Treatment for Anxiety in Alcoholism
NCT00248612 · Boston Medical Center, Other · Completed
Key facts
| NCT number | NCT00248612 |
|---|---|
| Title | Psychosocial and Medication Treatment for Anxiety in Alcoholism |
| Official title | CBT And Venlafaxine Treatments For Anxiety In Alcoholism |
| Lead sponsor | Boston Medical Center, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alcohol-Related Disorders, Anxiety Disorders |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Venlafaxine, CBT, Progressive muscle relaxation therapy (PMR), Placebo medication |
| Enrollment | 162 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Nov 4, 2005 |
| Last update posted | Jan 24, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: